Market Tracker

04/29 5:16pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

150.74
Delayed Data
As of Apr 29
 -2.94 / -1.91%
Today’s Change
89.76
Today|||52-Week Range
314.88
+0.93%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close153.68
Today’s open152.54
Day’s range149.26 - 155.50
Volume294,187
Average volume (3 months)723,725
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-67.38%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book6.23

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.10-0.31%
NBIXNeurocrine Bioscienc...-1.32-2.81%
GRFSGrifols SA-0.05-0.32%
CBPOChina Biologic Produ...-2.99-2.49%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)-$3.82
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts